ElmediX: Clinical Trials

2 trials sponsored by ElmediX, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow ElmediX: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
Whole-body hyperthermia, Standard-of-Care Systemic therapy - Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 2 / Phase 3Not yet recruitingElmediX952026-10-012026-07-17
Safety Study of Whole Body Hyperthermia for Advanced Cancer
Whole body hyperthermia, Standard of Care (SOC) chemotherapy according to the NCCN guidelines. - Advanced Cancer, Pancreatic Cancer Metastatic
Not applicableCompletedElmediX162021-07-282026-10-23

Conditions studied

Hyperthermia (1)

Interventions

Standard of Care (1)

Countries

Belgium (2)  ·  Spain (1)

Top investigators

Marc Peeters, MD PhD (1)

Results publications

PMID 41642747